Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in CADL — Candel Therapeutics, Inc.

CIK 720005 ST. PETERSBURG, FL
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$431,899
+$235,899 QoQ
Shares Held
41,932
+4.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 138 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $1,702,332,948 across 201 Biotechnology names. CADL ranks #126 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 556,876 $276,617,014
2 ALNY
Alnylam Pharmaceuticals, Inc.
 392,799 $118,244,281
3 REGN
Regeneron Pharmaceuticals, Inc.
 172,896 $107,807,571
4 RPRX
Royalty Pharma plc
 1,599,881 $89,705,325
5 INSM
INSMED Inc
 660,601 $70,433,276
6 KRYS
Krystal Biotech, Inc.
 158,675 $58,974,733
7 JAZZ
Jazz Pharmaceuticals plc
 228,645 $55,096,584
8 EXEL
Exelixis, Inc.
 941,571 $51,230,875

All Filings in CADL

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $431,899 41,932
2026-03-31 $196,000 40,000
2025-12-31 $186,450 33,000
2025-09-30 $113,036 22,164
2025-06-30 $112,149 22,164
2025-03-31 $127,972 22,650